Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-01-10 @ 12:36 AM
Study NCT ID:
NCT03292302
Status:
COMPLETED
Last Update Posted:
2023-08-22
First Post:
2017-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of ELX-02 in Healthy Adults
Sponsor:
Eloxx Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-30
First Submit QC Date:
None
Study First Post Date:
2017-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-17
Last Update Post Date:
2023-08-22
Last Update Post Date Type:
ACTUAL